Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Alster

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Frontiers in Aging Neuroscience|February 28, 2022
Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes-Infrequent Manifestations of the Most Common Form of Atypical ParkinsonismPatrycja Krzosek, Natalia Madetko, Anna Migda, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Potential Role of Transferrin and Vascular Cell Adhesion Molecule 1 in Differential Diagnosis Among Patients with Tauopathic Atypical Parkinsonian SyndromesNatalia Madetko-Alster, Dagmara Otto-Ślusarczyk, Marta Struga, et al.
Frontiers in Immunology|March 18, 2022
Anti-IgLON5 Disease - The Current State of Knowledge and Further PerspectivesNatalia Madetko, Weronika Marzec, Agata Kowalska, et al.
Neurology and Therapy|October 10, 2025
SGLT-2 Inhibitors in the Prevention and Progression of Neurodegenerative Diseases: A Narrative ReviewPaulina Kostrzewska, Paweł Kuca, Przemysław Witek, et al.
Diagnostics (Basel, Switzerland)|December 23, 2022
The Use of Cerebellar Hypoperfusion Assessment in the Differential Diagnosis of Multiple System Atrophy with Parkinsonism and Progressive Supranuclear Palsy-Parkinsonism PredominantNatalia Madetko-Alster, Piotr Alster, Bartosz Migda, et al.
Brain and Behavior|July 2, 2024
The potential significance of hepcidin evaluation in progressive supranuclear palsyPiotr Alster, Dagmara Otto-Ślusarczyk, Alicja Wiercińska-Drapało, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy-Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)Piotr Alster, Natalia Madetko-Alster, Bartosz Migda, et al.
Diagnostics (Basel, Switzerland)|August 26, 2023
The Role of the Evans Index and the Maximal Width of the Frontal Horns of the Lateral Ventricles in the Diagnostic Imaging of Progressive Supranuclear Palsy and Multiple-System AtrophyMichał Kutyłowski, Piotr Alster, Natalia Madetko-Alster, et al.
Frontiers in Neurology|March 7, 2019
Accumulation of Tau Protein, Metabolism and Perfusion-Application and Efficacy of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) Imaging in the Examination of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS)Piotr Alster, Natalia Katarzyna Madetko, Dariusz Mariusz Koziorowski, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 12, 2020
Is brain perfusion a differentiating feature in the comparison of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS)?Piotr Alster, Michał Nieciecki, Dariusz Koziorowski, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Frontiers in Aging Neuroscience|February 28, 2022
Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes-Infrequent Manifestations of the Most Common Form of Atypical ParkinsonismPatrycja Krzosek, Natalia Madetko, Anna Migda, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Potential Role of Transferrin and Vascular Cell Adhesion Molecule 1 in Differential Diagnosis Among Patients with Tauopathic Atypical Parkinsonian SyndromesNatalia Madetko-Alster, Dagmara Otto-Ślusarczyk, Marta Struga, et al.
Frontiers in Immunology|March 18, 2022
Anti-IgLON5 Disease - The Current State of Knowledge and Further PerspectivesNatalia Madetko, Weronika Marzec, Agata Kowalska, et al.
Neurology and Therapy|October 10, 2025
SGLT-2 Inhibitors in the Prevention and Progression of Neurodegenerative Diseases: A Narrative ReviewPaulina Kostrzewska, Paweł Kuca, Przemysław Witek, et al.
Diagnostics (Basel, Switzerland)|December 23, 2022
The Use of Cerebellar Hypoperfusion Assessment in the Differential Diagnosis of Multiple System Atrophy with Parkinsonism and Progressive Supranuclear Palsy-Parkinsonism PredominantNatalia Madetko-Alster, Piotr Alster, Bartosz Migda, et al.
Brain and Behavior|July 2, 2024
The potential significance of hepcidin evaluation in progressive supranuclear palsyPiotr Alster, Dagmara Otto-Ślusarczyk, Alicja Wiercińska-Drapało, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy-Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)Piotr Alster, Natalia Madetko-Alster, Bartosz Migda, et al.
Diagnostics (Basel, Switzerland)|August 26, 2023
The Role of the Evans Index and the Maximal Width of the Frontal Horns of the Lateral Ventricles in the Diagnostic Imaging of Progressive Supranuclear Palsy and Multiple-System AtrophyMichał Kutyłowski, Piotr Alster, Natalia Madetko-Alster, et al.
Frontiers in Neurology|March 7, 2019
Accumulation of Tau Protein, Metabolism and Perfusion-Application and Efficacy of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) Imaging in the Examination of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS)Piotr Alster, Natalia Katarzyna Madetko, Dariusz Mariusz Koziorowski, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 12, 2020
Is brain perfusion a differentiating feature in the comparison of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS)?Piotr Alster, Michał Nieciecki, Dariusz Koziorowski, et al.
Pageof 6